Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

One of the firms setting out its vision for our digital future is Pfizer. Its chief digital and technology officer Lidia Fonseca offered a fascinating insight into how one biggest pharmaceutical ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

Earnings are painting a mixed picture within the pharmaceutical space Tuesday morning, as Merck (MRK) and Pfizer (PFE) ...

Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...

Hims & Hers' “Sick of the System” spot not only generated the highest engagement of all pharma-related ads that aired during ...

Pfizer is to acquire NextWave Pharmaceuticals, which specializes in the development and commercialization of unique products for the treatment of ADHD and related central nervous system disorders ...